A class of drugs that quash hunger have shown striking results in trials and in practice. But can they help all people with obesity — and conquer weight stigma?
Long COVID is an often debilitating illness of severe symptoms that can develop during or following COVID-19. In this Review, Davis, McCorkell, Vogel and Topol explore our knowledge of long COVID and highlight key findings, including potential mechanisms, the overlap with other conditions and potential treatments. They also discuss challenges and recommendations for long COVID research and care.
A visual tour of unfolding threats and desperate attempts to reverse species' declines.
The proportion of publications that send a field in a new direction has plummeted over the last half-century.
A decline in disruptive science and technology over time is reported, representing a substantive shift in science and technology, which is attributed in part to the reliance on a narrower set of…
Long-term standardized monitoring reveals the scale of biodiversity losses.
Wolf behavioural, spatial, and serological data over 26 years show that wolf territory overlap with areas of high cougar density is a significant predictor of T. gondii infection. Further, infection…
Scientists are starting to work out how the gut microbiome can affect brain health. That might lead to better and easier treatments for brain diseases.
Detailed gene-activity map could pave way for more precise treatments for many more people with spinal-cord injuries.
Thirty years of pursuit have failed to yield a drug to take on one of the deadliest families of cancer-causing proteins. Now some researchers are taking another shot.
What we eat needs to be nutritious and sustainable. Researchers are trying to figure out what that looks like around the world.
«“which sea foods can we choose that are healthy for the ecosystem as well as healthy in the diet”»
A neuronal pathway that governs stress-induced hyperthermia.
Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
AI has the potential to reshape medicine and make healthcare more accurate, efficient and accessible; this Review discusses recent progress, opportunities and challenges toward achieving this goal.
The chimaeras lived up to 19 days — but some scientists question the need for such research.
«Japan lifted its ban on experiments with animal embryos containing human cells in 2019 and began funding such work that year.»
An almighty eruption, the cosmos remastered, swirling cells and more.
As interest in academia fades, scholars in PhD and master’s programmes are dubious about the value of their degree in advancing their professional lives, finds Nature survey.
Recent PhD graduate Lucy A. Taylor shares the advice she and her colleagues wish they had received.
Martha Gilmore has faced not only accusations of theft and lying, but also quiet isolation and the pain of watching racism bear down on others.
People tend to solve problems by adding features.
«Moreover, people could assume that existing features are there for a reason, and so looking for additions would be more effective.»
Rasha Shraim’s education helped her to think more deeply about ethics, logic and other big questions.
«Philosophy has expanded my critical and creative thinking. Philosophical arguments often lead to imaginative edge cases and a dive into hypotheticals, which I frequently find creatively stimulating.»
Understanding cognitive control can help your working life, says David Badre.
«returning to a hard task in this way comes with a ‘restart’ cost»
Psychiatrists have a dizzying array of diagnoses and not enough treatments. Hunting for the hidden biology underlying mental disorders could help.
A handful of experiments are raising questions about whether clumps of cells and disembodied brains could be sentient, and how scientists would know if they were.
The science supports that face coverings save lives, and yet the debate trundles on. How much evidence is enough?
Eight ways in which scientists hope to provide immunity to SARS-CoV-2 .
How does Refind curate?
It’s a mix of human and algorithmic curation, following a number of steps:
- We monitor 10k+ sources and 1k+ thought leaders on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
- In addition, our users save links from around the web using our Save buttons and our extensions.
- Our algorithm processes 100k+ new links every day and uses external signals to find the most relevant ones, focusing on timeless pieces.
- Our community of active users gets 5 links every day, tailored to their interests. They provide feedback via implicit and explicit signals: open, read, listen, share, add to reading list, save to «Made me smarter», «More/less like this», etc.
- Our algorithm uses these internal signals to refine the selection.
- In addition, we have expert curators who manually curate niche topics.
The result: lists of the best and most useful articles on hundreds of topics.
How does Refind detect «timeless» pieces?
We focus on pieces with long shelf-lives—not news. We determine «timelessness» via a number of metrics, for example, the consumption pattern of links over time.
How many sources does Refind monitor?
We monitor 10k+ content sources on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
Can I submit a link?
Indirectly, by using Refind and saving links from outside (e.g., via our extensions).
How can I report a problem?
When you’re logged-in, you can flag any link via the «More» (...) menu. You can also report problems via email to firstname.lastname@example.org
Who uses Refind?
100k+ smart people start their day with Refind. To learn something new. To get inspired. To move forward. Our apps have a 4.9/5 rating.
Is Refind free?
Yes, it’s free!
How can I sign up?
Head over to our homepage and sign up by email or with your Twitter or Google account.